Top news of the week: 14.07.2021.
Companies And Industries
Clinical Catch-Up: July 5-9
Last week presented a fair number of clinical trial news. Read on for more information.
Meet The Hosts of Season Four
Featuring our new hosts, Maria Wilson and Danielle Mandikian.
New CEOs Named at Two Biopharma Companies
Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.
Chicago Biopharma Builds Commercial Facility in China to Focus on Antibody Development
Sparx Therapeutics is expanding its operations into Yangzhou, China, with the imminent construction of a 1.2 million square foot facility for its commercial production.
GSK cancer head Hoos exits, takes top role at biotech Scorpion
GlaxoSmithKline's head of oncology Axel Hoos has resigned from the company, and will take up a new role as chief executive of US biotech Scorpion Therapeutics
Global Biotech Announces Results from Phase III Trials for Myeloma Treatment
The study, which compared the same treatment combination to pomalidomide plus dexamethasone covered 495 patients from over a hundred hospitals in 21 countries.
COVID-19 offers appropriate opportunity to work on strategic research outcomes: Jitendra Singh
Singh said, India has huge resource material for research. It can offer the world exclusive preventive and therapeutic options, particularly considering the fact that Indian phenotype and ...
The Hidden Role of Biobanks in Covid-19 Research
While the pandemic presented a big challenge to the often underfunded biobanks, it also provided an opportunity for growth.